Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ecopipam hydrobromide
Cat. No.:
OB0425LY-029
Appearance:
Solid
Purity:
≥99.0%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Ecopipam hydrobromide is a compound that selectively antagonizes dopamine D1 receptors.
Synonyms:
SCH 39166 hydrobromide; 1227675-51-5; (6aS,13bR)-11-Chloro-7-methyl-5,6,6a,8,9,13b-hexahydronaphtho[1,2-a][3]benzazepin-12-ol;hydrobromide; (6aS,13bR)-11-Chloro-7-methyl-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphtho[2,1-b]azepin-12-ol hydrobromide; (6aS-trans)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5Hbenzo[d]naphth[2,1-b]azepin-12-ol hydrobromide
CAS No.:
2587360-22-1
Compound CID:
16759171
Formula:
C19H21BrClNO
Formula Weight:
394.73
Specification
Target:
Dopamine receptor; 5-HT receptor; Adrenergic receptor
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
Ecopipam hydrobromide can be used for psychiatric disorders such as depression, anxiety, and obesity research.
